Breath tests sustainability in hospital settings: cost analysis and reimbursement in the Italian National Health System.

摘要: The high demand of Breath Tests (BT) in many gastroenterological conditions time limited resources for health care systems, generates increased interest cost analysis from the point view delivery services to better understand how use money generate value. This study aims measure C13 Urea and other most utilized breath tests order describe key aspects costs reimbursements looking at economic sustainability hospital. A hospital based cost-analysis main commonly an ambulatory setting is performed. Mean salary professional nurses gastroenterologists, drugs/preparation used disposable materials, purchase depreciation instrument testing was estimate cost, while are on 2013 Italian National Health System pricelist. Variables that could influence model considered sensitivity analyses. mean C13--Urea, Lactulose Lactose BT are, respectively, Euros 30,59; 45,20 30,29. reimbursement often doesn't cover analysis, especially considering scenario with lower number exam. On contrary, performance all except influenced by drugs cost. However, consideration about difference between Regional pricelist done. Our shows national rates H2 testing, they do not sufficiently BT, particularly urea test. real strength these non invasive should be overall organization inpatient outpatient clinic, accounting complete diagnostic pathway each gastrointestinal disease.